- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02732197
Effects of Sedation on Spinal Anesthesia-induced Maternal Hypotension
Effects of Sedation on Spinal Anesthesia-induced Maternal Hypotension in Preoperatively Anxious Parturients Undergoing Urgent Category-1 Cesarean Section: A Historical Cohort Study
Background: This study was designed to investigate the effect of sedation on the occurrence of maternal hypotension in preoperatively anxious parturients undergoing urgent category-1 Cesarean section (C/S) under spinal anesthesia.
Methods: After institutional ethics committee approval, prospectively collected data of 1824 parturients undergoing C/S were reviewed. Parturients with high preoperative anxiety scores (visual analogue scale for anxiety (VAS-A)≥70) undergoing C/S under spinal anesthesia with thiopental (Group S=49) and without any other type of sedation (Group NS=53) were included in the analysis. Hemodynamic parameters were documented and maximum systolic arterial pressure (SAP) reductions from the baseline after spinal anesthesia were calculated. Incidences of hypotension (SAP≥30% decrease from baseline or <100 mmHg) and bradycardia (HR<55 beats/min), and related-ephedrine and -atropine requirements were noted. Our primary endpoint was to compare the maximum SAP reductions from the baseline values in Groups S and NS. Secondary endpoints were incidences of hypotension and bradycardia, required ephedrine and atropine doses, newborn Apgar scores at 1st and 5th min.
Study Overview
Status
Intervention / Treatment
Detailed Description
Background: This study was designed to investigate the effect of thiopental sodium sedation on the occurrence of maternal hypotension in preoperatively anxious parturients undergoing urgent category-1 Cesarean section (C/S) under spinal anesthesia.
Methods: After institutional ethics committee approval, prospectively collected data of 1824 parturients undergoing C/S at Van Training and Research Hospital between August 2014 and February 2015 were reviewed. Parturients with high preoperative anxiety scores (visual analogue scale for anxiety (VAS-A)≥70) undergoing C/S under spinal anesthesia with thiopental (Group S=49) and without any other type of sedation (Group NS=53) were included in the analysis. All parturients received SA with hyperbaric bupivacaine 0.5% 2.5 mL. Hemodynamic parameters were documented and maximum systolic arterial pressure (SAP) reductions from the baseline after spinal anesthesia were calculated. Incidences of hypotension (SAP≥30% decrease from baseline or <100 mmHg) and bradycardia (HR<55 beats/min), and related-ephedrine and -atropine requirements were noted. All data were obtained from the surgical database and patient charts. Primary endpoint of our study was to compare the maximum SAP reductions from the baseline values in Groups S and NS. Secondary endpoints were incidences of hypotension and bradycardia, required ephedrine and atropine doses, newborn Apgar scores at 1st and 5th min.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Van, Turkey
- Van Training and Research Hospital, Department of Anesthesiology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Urgent category-1 C/S
- ASA physical status I-II
- Aged between 18 and 35 years
- Term (≥37 weeks) singleton pregnancy
- BMI <40 kg/m2
- Height >150 cm or <180 cm
- High preoperative anxiety scores (visual analogue scale for anxiety (VAS-A) ≥70)
- Spinal anesthesia with thiopental sodium sedation
- Spinal anesthesia without any sedation
Exclusion Criteria:
- Preoperative prehydration
- Placenta previa
- Placenta accreta
- Hypertension
- Pregnancy-induced hypertension
- Urgent category ≥2
- General anesthesia
- Spinal anesthesia with sedation other than thiopental sodium
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Sedation (S)
Parturients who received IV thiopental 2 mg kg-1 and if necessary additional 50 mg immediately after spinal anesthesia until reaching at least Ramsay sedation score of 3 (1: patient anxious, agitated or restless, 6: patient with no response to light glabella tap or loud auditory stimulus.).
|
Parturients who received IV thiopental 2 mg kg-1 and if necessary additional 50 mg immediately after spinal anesthesia until reaching at least Ramsay sedation score of 3 (1: patient anxious, agitated or restless, 6: patient with no response to light glabella tap or loud auditory stimulus.).
Other Names:
|
No sedation (NS)
Parturients who did not receive any sedative agent after the spinal anesthesia performance.
|
Parturients did not receive any type of sedation after spinal anesthesia.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximum systolic arterial pressure (SAP) reductions from the baseline values
Time Frame: 0-10 minutes
|
% SAP reduction after spinal anesthesia
|
0-10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of maternal hypotension
Time Frame: 0-30 minutes
|
Incidence of hypotension during the surgery (decrease in SAP >30% from baseline or an absolute value <100 mmHg)
|
0-30 minutes
|
Incidence of maternal bradycardia
Time Frame: 0-30 minutes
|
Incidence of bradycardia during the surgery (heart rate (HR) <55 beats min-1)
|
0-30 minutes
|
Ephedrine requirement
Time Frame: 0-30 minutes
|
Ephedrine 5 mg IV boluses were administered with 2 min intervals until SAP returned to a value of >100 mmHg
|
0-30 minutes
|
Atropine requirement
Time Frame: 0-30 minutes
|
Bolus of IV 0.5 mg atropine was given if bradycardia (HR <55 beats min-1) occurred
|
0-30 minutes
|
Incidence of maternal nausea
Time Frame: 0-30 minutes
|
If any during the Cesarean section, recorded
|
0-30 minutes
|
Incidence of maternal vomiting
Time Frame: 0-30 minutes
|
If any during the Cesarean section, recorded
|
0-30 minutes
|
Newborn Apgar score 1st min
Time Frame: 1st min
|
Apgar score at 1st min (0-3: severely depressed, 4-6: moderately depressed, 7-10: excellent condition)
|
1st min
|
Newborn Apgar score 5th min
Time Frame: 5th min
|
Apgar score at 5th min (0-3: severely depressed, 4-6: moderately depressed, 7-10: excellent condition)
|
5th min
|
Collaborators and Investigators
Investigators
- Principal Investigator: Cenk Sahan, MD, Design and conduct the study, review and analyze the data, and write the manuscript
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Hypotension
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Hypnotics and Sedatives
- GABA Modulators
- GABA Agents
- Anticonvulsants
- Thiopental
Other Study ID Numbers
- 2015/4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Odense University HospitalHvidovre University Hospital; Smith & Nephew, Inc.; University of Southern Denmark and other collaboratorsCompletedSurgical Wound Infection | Cesarean Section; Dehiscence | Complications; Cesarean Section | Infection; Cesarean Section | Complications; Cesarean Section, Wound, Dehiscence | Wound; Rupture, Surgery, Cesarean SectionDenmark
-
Virginia Commonwealth UniversityRecruitingCesarean SectionUnited States
-
University Tunis El ManarCompleted
-
Federico II UniversityCompletedCesarean SectionItaly
-
Virginia Commonwealth UniversityCompletedCesarean SectionUnited States
-
University of CalgaryCompleted
Clinical Trials on Sedation
-
Memorial Medical CenterTerminatedRespiratory InsufficiencyUnited States
-
Virginia Commonwealth UniversityNational Institutes of Health (NIH); American Lung AssociationTerminatedDepression | Quality of Life | Sedation | Post-traumatic Stress Disorder | Mechanical Ventilation
-
Poitiers University HospitalCompletedFracture | Dislocation | Reality Device | Reduction ProcedureFrance
-
Shandong UniversityWeihai Municipal Hospital; Qilu Hospital of Shandong University (Qingdao); Binzhou...UnknownEarly Detection of CancerChina
-
University of EdinburghGE Healthcare; Chief Scientist Office of the Scottish GovernmentCompletedCritical IllnessUnited Kingdom
-
Englewood Hospital and Medical CenterTerminated
-
Johns Hopkins UniversityNational Institute on Aging (NIA)CompletedDelirium | Hip FracturesUnited States
-
Melbourne HealthAbbott; University of Melbourne; Australian College of Critical Care NursesCompletedRespiration DisordersAustralia
-
University Hospital, Clermont-FerrandGroupe Hospitalier Pitie-Salpetriere; University Hospital Schleswig-Holstein; Hospital Clínico Universitario de ValenciaCompletedAcute Respiratory Distress Syndrome | Sedation | Invasive Mechanical Ventilation | Critically IllnessUnited States, France, Spain, Germany, Switzerland
-
Davinia WithingtonUnknownSedation | Mechanical Ventilation | Daily Sedative Interruption | Sedation Strategies | Sedation ProtocolsCanada